Clinical Trial Update: Study of A-101 Topical Solution for the Treatment of Common Warts [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for A-101 topical solution in treating common warts; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Wart

Drugs mentioned

• A-101

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Common Wart | Phase 3 | Status: COMPLETED | Results posted: 2020-10-05